HOOKIPA PHARMA INC (HOOK) Fundamental Analysis & Valuation

NASDAQ:HOOK • US43906K2096

Current stock price

0.8403 USD
-0.06 (-6.92%)
At close:
0.83 USD
-0.01 (-1.23%)
After Hours:

This HOOK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. HOOK Profitability Analysis

1.1 Basic Checks

  • In the past year HOOK has reported negative net income.
  • HOOK had a negative operating cash flow in the past year.
  • HOOK had negative earnings in each of the past 5 years.
  • In the past 5 years HOOK always reported negative operating cash flow.
HOOK Yearly Net Income VS EBIT VS OCF VS FCFHOOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • HOOK has a Return On Assets of -119.68%. This is in the lower half of the industry: HOOK underperforms 79.89% of its industry peers.
  • HOOK's Return On Equity of -215.12% is on the low side compared to the rest of the industry. HOOK is outperformed by 68.66% of its industry peers.
Industry RankSector Rank
ROA -119.68%
ROE -215.12%
ROIC N/A
ROA(3y)-47.11%
ROA(5y)-44.97%
ROE(3y)-79.69%
ROE(5y)-70.35%
ROIC(3y)N/A
ROIC(5y)N/A
HOOK Yearly ROA, ROE, ROICHOOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for HOOK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HOOK Yearly Profit, Operating, Gross MarginsHOOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. HOOK Health Analysis

2.1 Basic Checks

  • HOOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, HOOK has about the same amount of shares outstanding.
  • HOOK has less shares outstanding than it did 5 years ago.
  • HOOK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HOOK Yearly Shares OutstandingHOOK Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
HOOK Yearly Total Debt VS Total AssetsHOOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -12.59, we must say that HOOK is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -12.59, HOOK is doing worse than 77.36% of the companies in the same industry.
  • There is no outstanding debt for HOOK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.59
ROIC/WACCN/A
WACC9.58%
HOOK Yearly LT Debt VS Equity VS FCFHOOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • HOOK has a Current Ratio of 3.61. This indicates that HOOK is financially healthy and has no problem in meeting its short term obligations.
  • HOOK has a Current ratio of 3.61. This is comparable to the rest of the industry: HOOK outperforms 42.75% of its industry peers.
  • A Quick Ratio of 3.61 indicates that HOOK has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.61, HOOK is in line with its industry, outperforming 44.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.61
Quick Ratio 3.61
HOOK Yearly Current Assets VS Current LiabilitesHOOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HOOK Growth Analysis

3.1 Past

  • The earnings per share for HOOK have decreased strongly by -16.80% in the last year.
  • The Revenue for HOOK has decreased by -82.54% in the past year. This is quite bad
  • HOOK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.77% yearly.
EPS 1Y (TTM)-16.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.82%
Revenue 1Y (TTM)-82.54%
Revenue growth 3Y33.55%
Revenue growth 5Y29.77%
Sales Q2Q%-94.52%

3.2 Future

  • HOOK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.32% yearly.
  • HOOK is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.44% yearly.
EPS Next Y24.44%
EPS Next 2Y24.37%
EPS Next 3Y17.85%
EPS Next 5Y8.32%
Revenue Next Year-49.08%
Revenue Next 2Y-85.73%
Revenue Next 3Y-41.16%
Revenue Next 5Y-16.44%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HOOK Yearly Revenue VS EstimatesHOOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10M 20M 30M 40M 50M
HOOK Yearly EPS VS EstimatesHOOK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

0

4. HOOK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HOOK. In the last year negative earnings were reported.
  • Also next year HOOK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HOOK Price Earnings VS Forward Price EarningsHOOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HOOK Per share dataHOOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

  • HOOK's earnings are expected to grow with 17.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.37%
EPS Next 3Y17.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HOOK Dividend Analysis

5.1 Amount

  • No dividends for HOOK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

HOOK Fundamentals: All Metrics, Ratios and Statistics

HOOKIPA PHARMA INC

NASDAQ:HOOK (8/7/2025, 8:00:04 PM)

After market: 0.83 -0.01 (-1.23%)

0.8403

-0.06 (-6.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-06
Earnings (Next)11-12
Inst Owners34.13%
Inst Owner Change-100%
Ins Owners0.05%
Ins Owner Change0%
Market Cap10.25M
Revenue(TTM)9.35M
Net Income(TTM)-73.31M
Analysts45.71
Price Target29.07 (3359.48%)
Short Float %0.28%
Short Ratio0.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-128.61%
Min EPS beat(2)-241.28%
Max EPS beat(2)-15.95%
EPS beat(4)1
Avg EPS beat(4)-65.15%
Min EPS beat(4)-241.28%
Max EPS beat(4)15.62%
EPS beat(8)3
Avg EPS beat(8)-6.22%
EPS beat(12)6
Avg EPS beat(12)0.49%
EPS beat(16)7
Avg EPS beat(16)-4.9%
Revenue beat(2)0
Avg Revenue beat(2)-60.69%
Min Revenue beat(2)-79.59%
Max Revenue beat(2)-41.79%
Revenue beat(4)0
Avg Revenue beat(4)-57.44%
Min Revenue beat(4)-82.17%
Max Revenue beat(4)-26.23%
Revenue beat(8)3
Avg Revenue beat(8)127.91%
Revenue beat(12)4
Avg Revenue beat(12)79.48%
Revenue beat(16)6
Avg Revenue beat(16)52.08%
PT rev (1m)0%
PT rev (3m)44.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.61%
EPS NY rev (1m)0%
EPS NY rev (3m)0.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)29.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.1
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB 0.3
EV/EBITDA N/A
EPS(TTM)-5.84
EYN/A
EPS(NY)-1.59
Fwd EYN/A
FCF(TTM)-4.33
FCFYN/A
OCF(TTM)-4.33
OCFYN/A
SpS0.77
BVpS2.79
TBVpS2.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -119.68%
ROE -215.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.11%
ROA(5y)-44.97%
ROE(3y)-79.69%
ROE(5y)-70.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.92%
Cap/Sales 1.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.61
Quick Ratio 3.61
Altman-Z -12.59
F-Score2
WACC9.58%
ROIC/WACCN/A
Cap/Depr(3y)87.86%
Cap/Depr(5y)118.36%
Cap/Sales(3y)18.78%
Cap/Sales(5y)27.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.82%
EPS Next Y24.44%
EPS Next 2Y24.37%
EPS Next 3Y17.85%
EPS Next 5Y8.32%
Revenue 1Y (TTM)-82.54%
Revenue growth 3Y33.55%
Revenue growth 5Y29.77%
Sales Q2Q%-94.52%
Revenue Next Year-49.08%
Revenue Next 2Y-85.73%
Revenue Next 3Y-41.16%
Revenue Next 5Y-16.44%
EBIT growth 1Y-50.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-105.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-88.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.69%
OCF growth 3YN/A
OCF growth 5YN/A

HOOKIPA PHARMA INC / HOOK Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HOOKIPA PHARMA INC (HOOK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to HOOK.


Can you provide the valuation status for HOOKIPA PHARMA INC?

ChartMill assigns a valuation rating of 0 / 10 to HOOKIPA PHARMA INC (HOOK). This can be considered as Overvalued.


Can you provide the profitability details for HOOKIPA PHARMA INC?

HOOKIPA PHARMA INC (HOOK) has a profitability rating of 0 / 10.


How financially healthy is HOOKIPA PHARMA INC?

The financial health rating of HOOKIPA PHARMA INC (HOOK) is 7 / 10.